MYCBP2 and lip and oral cavity carcinoma: However, downregulation of RGS12 in oral cancer inhibits the MYCBP2 activity, which further causes decreased ciliogenesis, increased M2 TAMs polarization, and promotes oral cancer growth (Fig. 10).